Viewing Study NCT00256204


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2025-12-25 @ 5:36 PM
Study NCT ID: NCT00256204
Status: COMPLETED
Last Update Posted: 2012-01-12
First Post: 2005-11-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-11
Start Date Type: None
Primary Completion Date: 2008-04
Primary Completion Date Type: ACTUAL
Completion Date: 2009-06
Completion Date Type: ACTUAL
First Submit Date: 2005-11-16
First Submit QC Date: None
Study First Post Date: 2005-11-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2010-03-08
Results First Submit QC Date: None
Results First Post Date: 2011-06-21
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-01-10
Last Update Post Date: 2012-01-12
Last Update Post Date Type: ESTIMATED